Skip to main content
. 2022 Sep 2;13(6):2488–2518. doi: 10.1093/advances/nmac088

TABLE 5.

Summary of forest plot analyses of the effect of zinc supplementation in infants and children aged ≤3 y on serum ferritin (μg/L), analyzed by duration, chemical formula, and comparator group1

Group/subgroup References Mean difference 95% CI P I 2
Children receiving interventions for <3 mo by zinc dose
 <5 mg/d (48) −3.00 −22.84, 16.84 NA
 5–10 mg/d (48) −3.79 −16.21, 8.63 0
 10.1–20 mg/d (51) −0.10 −3.85, 3.65 NA
 Overall −0.49 −4.02, 3.04 0.79 0
Children receiving interventions for >3 mo by zinc dose
 <5 mg/d (19, 34) −1.85 −9.37, 5.67 0
 5–10 mg/d (12, 26, 29, 31, 35, 39, 40, 47, 70–72, 74, 75) −2.32 −5.18, −0.53 99
 10.1–20 mg/d (59) −3.23 −8.40, 1.94 0
 Zn bolus (18, 28) 3.09 −2.25, 8.43 0
 Overall −1.80 −4.31, −0.72 0.16 98
Children receiving zinc through zinc gluconate by zinc dose
 Zn bolus2 (18) 1.30 −5.84, 8 NA
 Overall 1.30 −5.84, 8 0.72 NA
Children receiving zinc through zinc sulfate by zinc dose
 <5 mg/d (34, 48) −4.11 −11.95, 3.73 0
 5–10 mg/d (12, 26, 29, 35, 39, 40, 47, 48, 71, 72, 75) −2.50 −6.69, 1.70 99
 10.1–20 mg/d (51) −0.10 −3.85, 3.65 NA
 Overall −2.48 −6.30, 1.34 0.20 99
Children receiving zinc through zinc acetate by zinc dose
 10.1–20 mg/d (28) 5.35 −2.68, 13.39 0
 Overall 5.35 −2.68, 13.39 0.19 0
Children receiving zinc through an unstated approach by zinc dose
 5–10 mg/d (31, 70, 74) −0.93 −2.46, 0.61 78
 Overall −0.93 −2.46, 0.61 0.24 78
Children receiving zinc through an “other” approach by zinc dose
 <5 mg/d (19) 6.65 −9.21, 22.51 NA
 10.1–20 mg/d (59) −3.23 −8.40, 1.94 0
 Overall −2.28 −7.19, 2.63 0.36 0
Children receiving zinc vs. placebo by zinc dose
 <5 mg/d (19) 6.65 −9.21, 22.51 NA
 5–10 mg/d (12, 29, 39, 40, 47, 70–72, 74, 75) −0.56 −2.35, 1.23 90
 10.1–20 mg/d (59) −3.20 −9.33, 2.93 NA
 Zn bolus2 (18, 28) 2.75 −3.30, 8.79 0
 Overall −0.41 −2.08, 1.25 0.63 86
Children receiving low- compared with high-dose zinc
 5–10 mg/d (48, 74) −8.10 −18.98, 2.78 45
 Overall −8.10 −18.98, 2.78 0.14 45
1

NA, not applicable.

2

Bolus doses given as follows: Baqui et al. (28) 20 mg/d once weekly; Bates et al. (18) 70 mg/d twice weekly.